Physician profile
Travis J Hanson
NPI 1700197498
$325.29
in general payments reported to CMS, 2019-2025
7 companies · $38.46 in 2025
The $38.46 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.27 · 2020: $16.24 · 2023: $129 · 2024: $104 · 2025: $38.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.40 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $141.16 | 2019-2023 | Nucala, Trelegy Ellipta, Arexvy |
| Intuitive Surgical, INC. | $86.17 | 2024 | |
| Insmed, INC. | $33.62 | 2020-2025 | Brinsupri |
| Inspire Medical Systems, INC. | $21.08 | 2025 | Inspire |
| Genzyme Corporation | $17.89 | 2024 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 | |
| Mylan Specialty L.P. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.